Abstract
In some patients with moderate-to-severe asthma, particularly those with noneosinophilic inflammation, the disease remains uncontrolled. This trial evaluated the efficacy and safety of tezepelumab ...
Cite
CITATION STYLE
APA
Corren, J., Parnes, J. R., Wang, L., Mo, M., Roseti, S. L., Griffiths, J. M., & van der Merwe, R. (2017). Tezepelumab in Adults with Uncontrolled Asthma. New England Journal of Medicine, 377(10), 936–946. https://doi.org/10.1056/nejmoa1704064
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free